Guardian Pharmacy Services, Inc. (GRDN) EBITDA
- 2026-06-30: Basis Reported; EBITDA $26.45M*; Operating income $20.64M; Depreciation and amortization $5.81M*.
- 2026-03-31: Basis Reported; EBITDA $23.65M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $36.5M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $22.19M*; Operating income $16.35M; Depreciation and amortization $5.84M*.
Complete source-backed ebitda history.
- Available history
- 2024-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $26.45M* | $20.64M | $5.81M* | (m) | (m) | (m) | $30.02M* | $271.72M | (m) | $59.40M | $7.67M |
|---|
| 2026-03-31 | Reported | $23.65M | (m) | (m) | (m) | 7.03% | (m) | $6.06M | $260.29M | (m) | $58.63M | $4.75M |
|---|
| 2025-12-31 | Reported | $36.5M | (m) | (m) | (m) | 9.18% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $22.19M* | $16.35M | $5.84M* | (m) | (m) | (m) | $28.17M* | $302.71M | (m) | $58.37M | $7.04M |
|---|
| 2025-06-30 | Reported | $18.07M* | $12.58M | $5.49M* | (m) | (m) | (m) | $19.94M* | $276.19M | (m) | $55.57M | $3.76M |
|---|
| 2025-03-31 | Reported | $18.27M | (m) | (m) | (m) | 5.55% | (m) | $17.55M | $264.96M | (m) | $51.34M | $3.83M |
|---|
| 2024-12-31 | Reported | $21.91M | (m) | (m) | (m) | 6.47% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$99.62M* | -$104.61M | $4.99M* | (m) | (m) | (m) | -$2.16M* | $253.51M | (m) | $165.49M | $176.00K |
|---|
| 2024-06-30 | Reported | $21.88M* | $17.00M | $4.87M* | (m) | (m) | (m) | $29.13M* | $238.75M | (m) | $44.28M | $0.00 |
|---|
| 2024-03-31 | Reported | $12.68M | (m) | (m) | (m) | 4.61% | (m) | $8.65M | $220.31M | (m) | $47.17M | $0.00 |
|---|
| 2023-09-30 | Reported | (m) | -$6.33M | (m) | (m) | (m) | (m) | (m) | $210.55M | (m) | $58.52M | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $95.04M | (m) | (m) | (m) | 6.56% | (m) | $100.25M | $1.16B | (m) | $220.02M | $24.46M |
|---|
| 2024-12-31 | Reported | -$43.15M | (m) | (m) | (m) | -3.51% | (m) | $57.96M | $984.04M | (m) | $307.29M | $4.56M |
|---|